List of GlycoMimetics patents

Patents where

Current Assignee

Name

GlycoMimetics

Name	Description	Patent Applicant	Current Assignee	Patent Jurisdiction	Patent Number	Date of Patent
‌ US Patent 11707474 Methods for treating acute myeloid leukemia and related conditions	Patent 11707474 was granted and assigned to GlycoMimetics on July, 2023 by the United States Patent and Trademark Office.	GlycoMimetics	GlycoMimetics	United States Patent and Trademark Office	11707474	July 25, 2023
‌ US Patent 10526361 E-selectin antagonist compounds, compositions, and methods of use	Patent 10526361 was granted and assigned to GlycoMimetics on January, 2020 by the United States Patent and Trademark Office.	GlycoMimetics	GlycoMimetics	United States Patent and Trademark Office	10526361	January 7, 2020
‌ US Patent 9109002 E-selectin antagonist compounds, compositions, and methods of use	Patent 9109002 was granted and assigned to GlycoMimetics on August, 2015 by the United States Patent and Trademark Office.	GlycoMimetics	GlycoMimetics	United States Patent and Trademark Office	9109002	August 18, 2015
‌ US Patent 7517980 Glycomimetric inhibitors of the PA-IL lectin, PA-IIL lectin or both the lectins from	Patent 7517980 was granted and assigned to GlycoMimetics on April, 2009 by the United States Patent and Trademark Office.		GlycoMimetics	United States Patent and Trademark Office	7517980	April 14, 2009
‌ US Patent 9796745 E-selectin antagonist compounds, compositions, and methods of use	Patent 9796745 was granted and assigned to GlycoMimetics on October, 2017 by the United States Patent and Trademark Office.	GlycoMimetics	GlycoMimetics	United States Patent and Trademark Office	9796745	October 24, 2017
‌ US Patent 7728117 Heterobifunctional pan-selectin inhibitors	Patent 7728117 was granted and assigned to GlycoMimetics on June, 2010 by the United States Patent and Trademark Office.		GlycoMimetics	United States Patent and Trademark Office	7728117	June 1, 2010
‌ US Patent RE44778 Heterobifunctional pan-selectin inhibitors	Patent RE44778 was granted and assigned to GlycoMimetics on February, 2014 by the United States Patent and Trademark Office.		GlycoMimetics	United States Patent and Trademark Office	RE44778	February 25, 2014
‌ US Patent 8633303 Heterobifunctional pan-selectin inhibitors	Patent 8633303 was granted and assigned to GlycoMimetics on January, 2014 by the United States Patent and Trademark Office.		GlycoMimetics	United States Patent and Trademark Office	8633303	January 21, 2014
‌ US Patent 7989601 Heterobifunctional pan-selectin inhibitors	Patent 7989601 was granted and assigned to GlycoMimetics on August, 2011 by the United States Patent and Trademark Office.		GlycoMimetics	United States Patent and Trademark Office	7989601	August 2, 2011
‌ US Patent 8258290 Glycomimetic inhibitors of the PA-IL lectin, PA-IIL lectin or both the lectins from	Patent 8258290 was granted and assigned to GlycoMimetics on September, 2012 by the United States Patent and Trademark Office.		GlycoMimetics	United States Patent and Trademark Office	8258290	September 4, 2012
‌ US Patent 11332491 E-selectin antagonist compounds, compositions, and methods of use	Patent 11332491 was granted and assigned to GlycoMimetics on May, 2022 by the United States Patent and Trademark Office.	GlycoMimetics	GlycoMimetics	United States Patent and Trademark Office	11332491	May 17, 2022
‌ US Patent 9867841 Compounds, compositions and methods using E-selectin antagonists for mobilization of hematopoietic cells	Patent 9867841 was granted and assigned to GlycoMimetics on January, 2018 by the United States Patent and Trademark Office.	GlycoMimetics	GlycoMimetics	United States Patent and Trademark Office	9867841	January 16, 2018
‌ US Patent 9534009 Pan-selectin inhibitor with enhanced pharmacokinetic activity	Patent 9534009 was granted and assigned to GlycoMimetics on January, 2017 by the United States Patent and Trademark Office.	GlycoMimetics	GlycoMimetics	United States Patent and Trademark Office	9534009	January 3, 2017
‌ US Patent 7741312 Compounds and methods for inhibiting selectin-mediated function	Patent 7741312 was granted and assigned to GlycoMimetics on June, 2010 by the United States Patent and Trademark Office.		GlycoMimetics	United States Patent and Trademark Office	7741312	June 22, 2010
‌ US Patent 7060685 Compounds and methods for inhibiting selectin-mediated function	Patent 7060685 was granted and assigned to GlycoMimetics on June, 2006 by the United States Patent and Trademark Office.		GlycoMimetics	United States Patent and Trademark Office	7060685	June 13, 2006
‌ US Patent 7361644 Specific antagonist for both E- and P-selectins	Patent 7361644 was granted and assigned to GlycoMimetics on April, 2008 by the United States Patent and Trademark Office.		GlycoMimetics	United States Patent and Trademark Office	7361644	April 22, 2008
‌ US Patent 11433086 Combination of T-cell checkpoint inhibitors with inhibitors of e-selectin or CXCR4, or with heterobifunctional inhibitors of both E-selectin and CXCR4		GlycoMimetics	GlycoMimetics	United States Patent and Trademark Office	11433086	September 6, 2022
‌ US Patent 8410066 Heterobifunctional inhibitors of E-selectins and CXCR4 chemokine receptors	Patent 8410066 was granted and assigned to GlycoMimetics on April, 2013 by the United States Patent and Trademark Office.		GlycoMimetics	United States Patent and Trademark Office	8410066	April 2, 2013
‌ US Patent 7135301 Detection and treatment of prostate cancer	Patent 7135301 was granted and assigned to GlycoMimetics on November, 2006 by the United States Patent and Trademark Office.		GlycoMimetics	United States Patent and Trademark Office	7135301	November 14, 2006
‌ US Patent 8026222 Methods of use of glycomimetics with replacements for hexoses and n-acetyl hexosamines	Patent 8026222 was granted and assigned to GlycoMimetics on September, 2011 by the United States Patent and Trademark Office.		GlycoMimetics	United States Patent and Trademark Office	8026222	September 27, 2011
‌ US Patent 8361975 Compounds and methods for treatment of sickle cell or complications associated therewith	Patent 8361975 was granted and assigned to GlycoMimetics on January, 2013 by the United States Patent and Trademark Office.		GlycoMimetics	United States Patent and Trademark Office	8361975	January 29, 2013
‌ US Patent 8039442 Compounds and methods for treatment of sickle cell disease or complications associated therewith	Patent 8039442 was granted and assigned to GlycoMimetics on October, 2011 by the United States Patent and Trademark Office.		GlycoMimetics	United States Patent and Trademark Office	8039442	October 18, 2011
‌ US Patent 7964569 Glycomimetic replacements for hexoses and N-acetyl hexosamines	Patent 7964569 was granted and assigned to GlycoMimetics on June, 2011 by the United States Patent and Trademark Office.		GlycoMimetics	United States Patent and Trademark Office	7964569	June 21, 2011
‌ US Patent 8921328 E-selectin antagonists	Patent 8921328 was granted and assigned to GlycoMimetics on December, 2014 by the United States Patent and Trademark Office.		GlycoMimetics	United States Patent and Trademark Office	8921328	December 30, 2014
‌ US Patent 11197877 Galactopyranosyl-cyclohexyl derivauves as E-selectin antagonists	Patent 11197877 was granted and assigned to GlycoMimetics on December, 2021 by the United States Patent and Trademark Office.	GlycoMimetics	GlycoMimetics	United States Patent and Trademark Office	11197877	December 14, 2021

Results per page:

39 results

0 selected

39 results

0 selected